For example, high expression levels of ERCC1 and BRCA1, which are crucial for DNA repair, negatively affect the efficacy of platinum drugs and are thought to be a major predictor of tumor responses to platinum-based chemotherapy [8,9]. The gene discussed is BRCA1; the disease is neoplasm.